INTEGRA LIFESCIENCES HOLDINGS CORP IART
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
5/9
Piotroski F — financial health
1.17
Altman Z″ — distress risk · grey
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $1.6B | -$516.5M | — | -$31.1M | $1.0B |
| 2024 | $1.6B | -$6.9M | — | $25.0M | $1.5B |
| 2023 | $1.5B | $67.7M | — | $73.1M | $1.6B |
| 2022 | $1.6B | $180.6M | — | $222.1M | $1.8B |
| 2021 | $1.5B | $169.1M | — | $264.4M | $1.7B |
| 2020 | $1.4B | $133.9M | $851.0M | $164.9M | $1.5B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| BRADLEY KEITH | director | 2026-05-09 | Tax withheld | 882 | $13.92 |
| HILL BARBARA B | director | 2026-05-07 | Grant | 6,638 | — |
| HILL BARBARA B | director | 2026-05-07 | Grant | 17,700 | — |
| McBreen Michael J. | EVP & President, CSS | 2026-03-11 | Tax withheld | 7,247 | $9.61 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | 2026-03-11 | Tax withheld | 861 | $9.61 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | 2026-03-11 | Option exercise | 18,922 | — |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | 2026-03-11 | Tax withheld | 5,190 | $9.61 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | 2026-03-10 | Tax withheld | 601 | $9.55 |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.17 (grey)
- Working capital / assets 0.195
- Retained earnings / assets 0.118
- EBIT / assets -0.137
- Equity / liabilities 0.408
Source: SEC EDGAR filings · CIK 0000917520 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.